Endothelial nanomedicine for the treatment of pulmonary disease.

Endothelial nanomedicine for the treatment of pulmonary disease.

Item
http://www.wikidata.org/entity/Q38267984
Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsSystems approaches to design of targeted therapeutic delivery.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.Non-affinity factors modulating vascular targeting of nano- and microcarriersChemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award-winning Proposal.Inhalation therapies in acute respiratory distress syndrome.The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.
P2860

Endothelial nanomedicine for the treatment of pulmonary disease.

Item
http://www.wikidata.org/entity/Q38267984
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Endothelial nanomedicine for the treatment of pulmonary disease.
@en
type
label
Endothelial nanomedicine for the treatment of pulmonary disease.
@en
prefLabel
Endothelial nanomedicine for the treatment of pulmonary disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Endothelial nanomedicine for the treatment of pulmonary disease
@en
P2093
P2860
P304
P31
P356
10.1517/17425247.2015.961418
P407
P433
P478
P50
P577
P698
P921